As of 2025-08-02, the Relative Valuation of SciClone Pharmaceuticals (Holdings) Ltd (6600.HK) is 60.06 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 18.72 HKD, the upside of SciClone Pharmaceuticals (Holdings) Ltd based on Relative Valuation is 220.8%.
The range of the Relative Valuation is 37.95 - 83.66 HKD.
| Range | Selected | |
| Trailing P/E multiples | 22.8x - 43.2x | 36.0x |
| Forward P/E multiples | 17.3x - 28.6x | 23.0x |
| Fair Price | 37.95 - 83.66 | 60.06 |
| Upside | 102.7% - 346.9% | 220.8% |
| Date | P/E |